Syncope as a probable side effect to combination antiretroviral therapy initiated during primary HIV-1 infection

被引:0
作者
Lybaek, Dorte [1 ]
Larsen, Carsten Schade [1 ]
机构
[1] Aarhus Univ Hosp, Skejby Hosp, Dept Infect Dis, DK-8200 Aarhus, Denmark
关键词
D O I
10.1071/SH07088
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
A previously healthy young man experienced several episodes of syncope while being treated with tenofovir, emtricitabine and nevirapine initiated during primary HIV-1 infection. Symptoms disappeared after discontinuation of antiretroviral therapy and we suggest that syncope may be a side effect to one of the three antiretroviral drugs that has not been described previously.
引用
收藏
页码:69 / 71
页数:3
相关论文
共 16 条
  • [11] Efficacy and safety of emtricitabine vs stavudine in combination therapy in anti retroviral-naive patients - A randomized trial
    Saag, MS
    Cahn, P
    Raffi, F
    Wolff, M
    Pearce, D
    Molina, JM
    Powderly, W
    Shaw, AL
    Mondou, E
    Hinkle, J
    Borroto-Esoda, K
    Quinn, JB
    Barry, DW
    Rousseau, F
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (02): : 180 - 190
  • [12] Is antiretroviral treatment of primary HIV infection clinically justified on the basis of current evidence?
    Smith, DE
    Walker, BD
    Cooper, DA
    Rosenberg, ES
    Kaldor, JA
    [J]. AIDS, 2004, 18 (05) : 709 - 718
  • [13] STEINGROVER R, 2007, 14 C RETR OPP INF
  • [14] Immunological and virological impact of highly active antiretroviral therapy initiated during acute HIV-1 infection
    Streeck, Hendrik
    Jessen, Heiko
    Alter, Galit
    Teigen, Nickolas
    Waring, Mike T.
    Jessen, Arne
    Stahmer, Ingrid
    van Lunzen, Jan
    Lichterfeld, Mathias
    Gao, Xiaojiang
    Allen, Todd M.
    Carrington, Mary
    Walker, Bruce D.
    Rockstroh, Juergen K.
    Altfeld, Marcus
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2006, 194 (06) : 734 - 739
  • [15] Gynecomastia and potent antiretroviral therapy
    Strub, C
    Kaufmann, GR
    Flepp, M
    Egger, M
    Kahlert, C
    Cavassini, M
    Battegay, M
    [J]. AIDS, 2004, 18 (09) : 1347 - 1349
  • [16] Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study
    van Leth, F
    Phanuphak, P
    Ruxrungtham, K
    Baraldi, E
    Miller, S
    Gazzard, B
    Cahn, P
    Lalloo, UG
    van der Westhuizen, IP
    Malan, DR
    Johnson, MA
    Santos, BR
    Mulcahy, F
    Wood, R
    Levi, GC
    Reboredo, G
    Squires, K
    Cassetti, I
    Petit, D
    Raffi, F
    Katlama, C
    Murphy, RL
    Horban, A
    Dam, JP
    Hassink, E
    van Leeuwen, R
    Robinson, P
    Wit, FW
    Lange, JMA
    [J]. LANCET, 2004, 363 (9417) : 1253 - 1263